IRVINE, Calif., July 27, 2009 (GLOBE NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO), a leading provider of medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, announced today that it will participate in the BMO Capital Markets 9th Annual Focus on Healthcare Conference on Wednesday, August 5. The presentation by Lloyd Malchow, Chairman, President and Chief Executive Officer of SenoRx will begin at 9:00 a.m. EDT.
Investors and others interested are invited to listen to the live webcast which will be accessible at http://www.bmocm.com/conferences/2009healthcare/webcast/. A replay of the webcast will be available approximately 24 hours following the presentation and may be accessed at the same web address.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(r) vacuum-assisted breast biopsy system and Contura(tm) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3605